Managed Healthcare Executive

06/12/2026

Today’s healthcare leaders are being asked to solve increasingly complex challenges—health systems are navigating evolving Medicare and Medicaid policies, shifts in specialty pharmacy strategy, AI adoption, drug pricing pressures and financial sustainability.

That’s why we’re excited to announce the launch of the Health System Executive Summit. This event unites executive, clinical, pharmacy, policy and operational leaders for focused conversations on the issues shaping healthcare delivery today and tomorrow.

Hear directly from health system leaders, exchange ideas with peers and gain practical insights to help guide strategy in a rapidly evolving healthcare landscape.

Register today: https://hubs.li/Q04lfzPd0

06/12/2026

Migraine is the #1 cause of disability in young women globally — yet it's barely mentioned in women's health policy conversations.

A new piece in Managed Healthcare Executive by Julienne Verdi, http://J.D., executive director, Alliance for Headache Disorders Advocacy, makes a compelling case: migraine isn't just a headache. It's a complex neurological disease that affects women at 2–3x the rate of men, is deeply tied to hormonal changes across a woman's lifespan, and can derail careers, caregiving and daily life.

And yet — it remains largely absent from federal women's health frameworks, research funding priorities and clinical training.
https://hubs.li/Q04lfpnR0

06/11/2026

Can AI replace a doctor's eye when it comes to skin cancer? Not quite yet — at least not the most experienced ones, according to this new study published in JAMA Dermatology
https://hubs.ly/Q04l5Y9b0

06/10/2026

A new machine learning model built from routine EHR data can identify adults at highest risk for type 2 diabetes up to 10 years before onset.
Presented at ADA 2026, the Kaiser Permanente study achieved an AUC of http://0.883, with 80% sensitivity and 81% specificity at its optimal risk threshold. It also incorporated neighborhood-level factors like walkability and food environment, going beyond traditional clinical inputs.
With 60%+ of http://U.S. adults carrying at least one T2D risk factor, tools like this could help health systems finally target prevention where it matters most.
Full story here: https://hubs.li/Q04k--670

06/09/2026

Roughly half of payers currently excluding obesity GLP-1s report they would not cover them irrespective of price, reflecting entrenched skepticism beyond budget impact alone.

Discontinuation and weight regain meaningfully influence coverage decisions, with 72% citing at least moderate impact and real-world persistence for non-T2D users often under one year.

https://hubs.li/Q04kNyfT0

06/08/2026

The difference between being physician-led in name and physician-led in practice is becoming increasingly visible and increasingly important to distinguish, according to Sam Starbuck, president of Priva Care Partners
https://hubs.li/Q04kBSg20

06/04/2026

Researchers have long studied HIV stigma. But a Boston University psychologist is asking a different question: what happens to the shame patients carry inside?

Abigail W. Batchelder, Ph.D., M.P.H. and her team analyzed video recordings of 319 people newly diagnosed with HIV, looking for shame not just in what they said but in the words they chose and the way they held their bodies. Slumped shoulders. A head tilted down. A caved chest.

Results showed no single method of detecting shame told the full story, and each predicted different health outcomes.

Read the full interview here:

https://hubs.li/Q04k9MNJ0

06/03/2026

64% of providers say staffing shortages are reducing patient access, up from 57% just a year ago. And hiring alone is no longer enough to close the gap.

A different model is taking shape. Health systems are beginning to distribute work between AI and human agents, letting AI handle the high-volume, repetitive interactions like scheduling, reminders, and eligibility checks, while human staff focus on the complex, high-value moments that require empathy, critical thinking and clinical coordination.
https://hubs.li/Q04jYnRq0

06/02/2026

"Shame" and "stigma" are often used interchangeably, but they're actually very different, and mixing them up can affect how we understand mental health.

Dr. Abigail Batchelder, M.P.H., Ph.D., a clinical psychologist and associate professor at Boston University Medical School, is shedding light on why this distinction is so important — especially when it comes to how external judgment influences the way we feel about ourselves.

Her research, recently published in the Journal of Health Psychology, explores shame measurement in relation to stress and coping following an HIV diagnosis.

Understanding the distinction between shame and stigma can change how we navigate societal pressures, according to Abigail Batchelder, M.P.H., Ph.D., clinical psychologist and associate professor at Boston University School of Medicine and Psychiatry. Batchelder is the corresponding author of ‘Mul...

06/02/2026

The future of cell and gene therapy depends on more than scientific breakthroughs. It depends on how healthcare stakeholders manage cost, reimbursement, risk and access.

Join our panel of expert leaders from Geisinger, USC Schaeffer Institute and Aradigm as they share insights on the economic realities shaping the next generation of cell and gene therapies and discuss the policy and market changes that could help patients access these innovative treatments.

Meet the speakers and reserve your spot for this important discussion on June 18 at 12 p.m. EDT.

Register here 👉 https://hubs.li/Q04jP4PZ0

Looking forward to learning from Michael A. Evans, MBA, RPh, FASHP, Darius Lakdawalla, Ph.D., William H. Shrank, M.D., M.S.H.S and Peter Wehrwein!